NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









apoQlar GmbH

apoQlar GmbH

Private
HamburgHealthcare & Life Scienceshttps://apoqlar.com/

Last Round

Series A

May 5, 2024

Total Funding Raised

$10.8M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

apoQlar GmbH is a medical software company that develops extended reality (XR) and mixed reality solutions for surgical planning, medical imaging, and clinical training.

Sector

Healthcare & Life Sciences

Verticals

AR/VR Experiences, Medical Imaging, Medical Devices, Data Visualization

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

mixed reality surgerysurgical planning softwaremedical XR3D holographic visualizationspatial AIcomputer vision segmentationdigital surgerymedical imaging softwareteleproctoringDICOM visualizationsurgical educationmedical device softwareXR healthcaresurgical navigationmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

apoQlar GmbH Comparables

Compare apoQlar GmbH with similar companies based on industry and business-model similarity.

apoQlar GmbH comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Medivis
89%
Realize Medical
86%
Surgical Theater
83%

apoQlar GmbH Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 5, 2024
SeedJul 5, 2023

Key People

Founding team and executive leadership

Ulrich Neidel

CTO & CISO

Executive Team

apoQlar GmbH Investors

Notable investors and investment history

apoQlar GmbH investors
InvestorRounds
YZR CapitalSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 20, 2026

    Open roles increased to 72, 8x the trailing average.

  • Nov 14, 2024

    Monthly visitors grew 91% MoM, reaching 2.1K.

apoQlar GmbH Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

apoQlar GmbH Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about apoQlar GmbH's valuation, stock price, and market status.

Firmographic Details

HeadquartersHamburg
Employee Range54
Year Founded2017
Last FundingMay 5, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.